Selected article for: "grand average and half life"

Author: Neha Jain; Uma Shankar; Prativa Majee; Amit Kumar
Title: Scrutinizing the SARS-CoV-2 protein information for the designing an effective vaccine encompassing both the T-cell and B-cell epitopes
  • Document date: 2020_4_1
  • ID: lmstdmyb_59
    Snippet: Analysis of the physiochemical properties of a multi-subunit vaccine helps in analyzing the optimal immune response of the vaccine and its stability inside the host. ProtParam was utilized for accessing the molecular weight, pI, stability and grand average of hydropathy (GRAVY) constant of the SARS-CoV-2 multi-epitope vaccine construct. Molecular weight . CC-BY-ND 4.0 International license author/funder. It is made available under a The copyright.....
    Document: Analysis of the physiochemical properties of a multi-subunit vaccine helps in analyzing the optimal immune response of the vaccine and its stability inside the host. ProtParam was utilized for accessing the molecular weight, pI, stability and grand average of hydropathy (GRAVY) constant of the SARS-CoV-2 multi-epitope vaccine construct. Molecular weight . CC-BY-ND 4.0 International license author/funder. It is made available under a The copyright holder for this preprint (which was not peer-reviewed) is the . https://doi.org/10.1101/2020.03.26.009209 doi: bioRxiv preprint of the vaccine construct was observed to be 65.3 kDa while pI value was 10.06. Instability index of 31.93 (<40) depicted the stable nature of the vaccine construct while the estimated half-life in mammalian reticulocytes was observed to be >30 hours. GRAVY constant of 0.213 depicted the hydrophilicity of the vaccine construct and was predicted to be soluble with a probability of `70 % as predicted by SolPro (Table 2) . Antigenicity is a preliminary requisite of a successful vaccine candidate. A vaccine construct must possess both immunogenicity and antigenicity to elicit the humoral and cell-mediated immune response.

    Search related documents:
    Co phrase search for related documents
    • antigenicity immunogenicity and instability index: 1
    • antigenicity immunogenicity and molecular weight: 1
    • antigenicity immunogenicity and multi epitope vaccine: 1, 2, 3, 4, 5, 6
    • antigenicity immunogenicity and multi epitope vaccine construct: 1
    • cell mediate and immune response: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19
    • cell mediate and molecular weight: 1
    • grand average and instability index: 1, 2, 3
    • grand average and molecular weight: 1, 2, 3, 4, 5
    • immune response and instability index: 1, 2
    • immune response and molecular weight: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • immune response and multi epitope vaccine: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • immune response and multi epitope vaccine construct: 1, 2, 3, 4, 5, 6, 7
    • immune response and multi subunit vaccine: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
    • instability index and molecular weight: 1, 2, 3, 4, 5, 6, 7, 8
    • instability index and multi epitope vaccine: 1, 2
    • instability index and multi subunit vaccine: 1
    • molecular weight and multi epitope vaccine: 1, 2, 3, 4
    • molecular weight and multi subunit vaccine: 1, 2